Optimizing cervical cancer screening: New study evaluates best approaches for HIV-positive women

Researchers evaluated the effectiveness and outcomes of various cervical cancer screening strategies for women living with HIV in Tanzania, supporting World Health Organisation’s (WHO’s) 2021 guidelines for reducing cervical cancer mortality in this high-risk group.

Daiichi Sankyo secures FDA approval for Vanflyta as AML treatment – Pharmaceutical Technology

The FDA opposed Vanflyta’s approval in 2019, citing concerns that the benefits of the drug’s efficacy did not justify the associated safety risks for AML

August 9, 2023

Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer

U.S. News & World Report released its annual ranking of top cancer centers. Darolutamide (Nubeqa) plus androgen deprivation therapy (ADT) improved radiologic progression-free survival over

July 20, 2024

Solid Phase II Trial Progress with Over 50% Patient Recruitment – Biotech Investments

Issuer: Berlin Cures Holding AG / Key word(s): Study 04.03.2024 / 12:00 CET/CEST The issuer is solely responsible for the content of this announcement. Berlin

March 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.